MIMS Education

Prevention against dengue: An innovative solution

Internal MedicineInfectious DiseasesFamily MedicineGeneral Practice

CAT3B: 1 point | An analog clock in color black

40 Minutes | A black calendar with white triangle in center that has a black exclamation point in the middle

04 Aug 2024

Enroll

Overview

About this course

Given the increasing burden of dengue worldwide and limitations to vector control strategies, live-attenuated vaccines are key for dengue prevention. In this e-Learning module, Dr Karen Nadua discusses the burden of dengue, current control measures and associated challenges, and the latest evidence for live-attenuated dengue vaccines in development or licensed. Dr Nadua is a Pediatric Infectious Disease Specialist at KK Women’s and Children’s Hospital and a Clinical Assistant Professor at SingHealth Duke-NUS Academic Medical Centre for the Pediatrics Academic Clinical Programme.

Learning outcomes

Upon completing this module, participants will be able to:

Describe the burden of dengue, especially pertaining to pediatric populations across Asia
Understand the limitations of vector control strategies
Distinguish the three key live-attenuated dengue vaccines in development or licensed

Topics covered

Dengue burden
Vector control and its limitations
Available efficacy, immunogenicity and safety data for CYD-TDV, TAK-003 and Butantan-DV

1 CME Point Available

Score at least 80% in the multiple-choice quiz.
A certificate can be downloaded upon successful completion. Please use the information on the certificate to claim your CME points.